GlassScriptPhysician profile
Marie Grosh
NPI 1497145601
$1,501.74
in general payments reported to CMS, 2019-2025
12 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $254 · 2024: $748 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $189.24 | 2023-2024 | Inspire |
| Neurocrine Biosciences, INC. | $172.40 | 2025 | |
| Edwards Lifesciences Corporation | $149.45 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alexion Pharmaceuticals, INC. | $133.83 | 2024 | |
| Abbvie INC. | $124.85 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $124.62 | 2024 | Uzedy |
| Axsome Therapeutics, INC. | $120.53 | 2025 | Symbravo |
| Jazz Pharmaceuticals INC. | $107.97 | 2025 | |
| Exact Sciences Corporation | $98.67 | 2025 | Cologuard Collection Kit |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $96.97 | 2024 | |
| Gilead Sciences, INC. | $92.99 | 2024 | Vemlidy |
| Sanofi-Aventis U.S. LLC | $90.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Grosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.